# Method Comparison Study of the Spartan FRX CYP2C19 Genotyping System Against Bi-directional Sequencing

> **NCT01718535** · — · COMPLETED · sponsor: **Spartan Bioscience Inc.** · enrollment: 327 (actual)

## Conditions studied

- Genotyping Techniques

## Interventions

- **DEVICE:** Spartan FRX CYP2C19 Test System

## Key facts

- **NCT ID:** NCT01718535
- **Lead sponsor:** Spartan Bioscience Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2012-11
- **Final completion:** 2012-12
- **Target enrollment:** 327 (ACTUAL)
- **Last updated:** 2013-08-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01718535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01718535, "Method Comparison Study of the Spartan FRX CYP2C19 Genotyping System Against Bi-directional Sequencing". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01718535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*